Heart Disease And Cannabis Use
AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

For listenersOffer from Amazon

Turn your wind-down time into listening time

  • Thousands of audiobooks, podcasts and originals
  • Listen on your phone, tablet or Echo — also offline
  • Cancel anytime
Try Audible free Free trial for new members
As an affiliate, we earn on qualifying purchases.

A review published in the July 2026 issue of Trends in Cardiovascular Medicine found conflicting evidence about cannabis use and heart attacks, strokes, coronary artery disease and heart failure. The most consistent association in the research was with heart rhythm problems, but differences in products and use patterns make cannabis-specific effects difficult to determine.

A review of research on cannabis and heart health, published in the July 2026 issue of Trends in Cardiovascular Medicine, found conflicting evidence about links to heart attacks, strokes, coronary artery disease and heart failure. The most consistent association the review identified was between cannabis use and heart rhythm problems, though the available research does not establish that cannabis causes them.

The analysis covered studies published from 2014 to mid-2025. Its findings point to an uneven evidence base: research on several serious cardiovascular outcomes does not yet offer a consistent answer, while studies more regularly report an association between cannabis use and problems with heart rhythm. The source report does not provide a pooled risk estimate or a specific measure of how much risk may change.

Interpreting the research is difficult because cannabis use varies by method, amount and frequency. People may smoke, vape or ingest cannabis, and products can contain different proportions of THC and CBD. The report also notes that many cannabis users use tobacco, alcohol or opioids, making it harder for researchers to separate cannabis’s effects from those of other substances.

The review’s authors describe different possible effects from the two cannabis components. THC, the compound chiefly responsible for cannabis’s euphoric effects, can increase heart rate, blood pressure and the heart’s demand for oxygen. The report says CBD may reduce inflammation and anxiety; these possible effects do not establish that CBD prevents heart disease or makes cannabis products safe for the heart.

At a glance
reportWhen: Review published July 2026; evidence co…
The developmentA review of research published from 2014 through mid-2025 found mixed evidence on cannabis and major heart conditions, while reporting a more consistent association with heart rhythm problems.

Heart Risks Depend on More Than Use

The findings matter because cannabis use is widespread and patterns are changing. The source report cites national surveys indicating that daily or near-daily cannabis use is now more common than daily or near-daily alcohol use. It says prevalence is highest among younger males, while use has also been rising among older adults and females.

For readers, the main point is not that cannabis has been shown to cause every cardiovascular condition studied. Rather, the research leaves substantial uncertainty while raising a particular concern about heart rhythm problems. THC’s reported effects on heart rate, blood pressure and oxygen demand may also be relevant for people with existing heart disease or risk factors, but the review does not quantify individual risk.

The report advises caution for cannabis users, especially those with heart disease or cardiovascular risk factors, while calling for better-quality data. It does not offer medical advice tailored to an individual’s circumstances; readers with questions about cannabis and their heart health should discuss them with a qualified health professional.

Products Worth Considering

OMRON Complete 2-in-1 Upper Arm Blood Pressure Monitor with EKG

OMRON Complete 2-in-1 Upper Arm Blood Pressure Monitor with EKG

As an affiliate, we earn on qualifying purchases.

Why Cannabis Studies Are Difficult

The review was produced amid broader cannabis legalization in the United States and increased use of marijuana and its active components, THC and CBD. It summarizes research rather than reporting a new clinical trial or proving a direct cause-and-effect relationship. Its conclusions reflect studies available through mid-2025, so they cannot account for later research.

An editorial accompanying the review raised questions about whether cannabis use in adolescence, when heart disease risk is generally low, differs in risk from use later in life, when cardiovascular risk is higher. The source report does not say that the evidence resolves this comparison. Differences in age, product composition, dose, frequency and other substance use remain obstacles to drawing firm conclusions.

“Heart risks from cannabis remain hazy but warrant caution.”

— Julie Corliss, executive editor of Harvard Heart Letter, in the Seniors Guide report

Key Risks Still Lack Clear Answers

The review found conflicting evidence on cannabis and heart attacks, strokes, coronary artery disease and heart failure. The reported association with rhythm problems is not, on its own, proof that cannabis causes those problems. The source material does not specify the strength of that association or establish which products, doses or patterns of use carry the greatest risk.

It also remains unclear how much findings reflect cannabis itself rather than tobacco, alcohol or opioids used by the same people. Variation in THC and CBD content and in smoking, vaping or ingestion adds further uncertainty. The report says higher-quality data are needed; it does not detail a single study design that would settle all of these questions.

Better Evidence Is Still Needed

The next step identified by the report is more higher-quality research that can better distinguish cannabis-specific effects from other substances and account for different products and use patterns. Studies that examine age and underlying heart risk may also help address questions raised by the accompanying editorial.

The review itself covers research only through mid-2025. The source report does not name a forthcoming study or give a timetable for new evidence, so it is not clear when researchers may be able to answer the remaining questions. For now, the report’s guidance is caution, especially for people with heart disease or risk factors.

Key Questions

Does the review show that cannabis causes heart disease?

No. The review found conflicting evidence on heart attacks, strokes, coronary artery disease and heart failure. An association in research does not by itself prove that cannabis causes a condition.

The review reported that the most consistent association was between cannabis use and heart rhythm problems. The source report does not give a specific risk estimate or establish cause and effect.

Why is it hard to study cannabis and heart health?

People use cannabis in different ways and amounts, and products contain varying ratios of THC and CBD. Tobacco, alcohol and opioid use among some cannabis users can also make it difficult to isolate cannabis’s effects.

Who should be especially cautious, according to the report?

The report recommends caution for people who use cannabis, particularly those with heart disease or risk factors for it. It does not provide individualized medical guidance; people with health concerns can speak with a qualified health professional.

Source: rss

This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.
You May Also Like

Life Sciences Surges In Global Coverage

Analysis shows a notable increase in media mentions of life sciences, with 13 times the baseline coverage in recent weeks, highlighting rising global interest.

Then A New Health Concern Surges In Global Coverage

A new health concern is rapidly spreading worldwide, with media coverage surging. Authorities are investigating, but details remain limited.

Melatonin Impairs Morning Cognition In Healthy Young Adults (2023)

A 2023 study finds melatonin intake impairs morning cognition in healthy young adults, raising questions about its use and safety.

Alcohol And The Brain; The Next Alzheimer’s Frontier; Mice With Human Brain Cells

A neurology roundup covers reporting on alcohol and the brain, tau drugs for Alzheimer’s, and mouse nervous systems integrating human brain cells.